Filing Flows › Novartis AG (NVS) › Q1 2025
Novartis AG (NVS) Q1 2025 earnings results (first quarter 2025)
6-K filed Apr 29, 2025
Novartis AG (NVS) reported revenue of $13.2B for the first quarter 2025 (Q1 2025), +12% from a year earlier. Operating margin was 35.2%, net earnings $3.6B (27.3% of revenue).
Novartis AG, Q1 2025: revenue $13.2B (+12% year over year), operating margin 35.2%, net earnings $3.6B, operating cash flow $3.6B. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $13.2B | — | +12% |
| Gross profit | $10.4B | — | +15% |
| Operating profit | $4.7B | — | +38% |
| Net earnings | $3.6B | — | +34% |
| Operating cash flow | $3.6B | — | +61% |
| Free cash flow | $3.4B | — | +66% |
What changed
Revenue was $13.2B in Q1 2025, up 12% year over year. US was the largest line at 43% of revenue. US added $1.1B year over year (up 24%), 80% of the total change. Canada and Latin America declined 6%.
Gross margin was 78.5%, up 2.3 points from a year earlier. Operating profit was $4.7B, a 35.2% margin (up 6.7 points year over year). Of the extra revenue versus a year earlier, 92% reached operating profit, above the 29% margin then. Operating expenses grew 1% against revenue growth of 12%. Net earnings were $3.6B, up 34% year over year. The effective tax rate was 18.1%.
Operating cash flow was $3.6B (up 61% year over year), 101% of net earnings. Capital expenditures of $0.25B left free cash flow of $3.4B.
Questions
What was Novartis AG's revenue in the first quarter 2025?
Novartis AG (NVS) reported revenue of $13.2B for the first quarter 2025 (Q1 2025), +12% from a year earlier.
Was Novartis AG profitable in the first quarter 2025?
Operating profit was $4.7B (35.2% of revenue) and net earnings $3.6B.
Source: Novartis AG 6-K on SEC EDGAR.